Bessemer Group’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Hold |
|
|||||
|
2025
Q1 | $827K | Hold |
|
|||||
|
2024
Q4 | $1.35M | Hold |
|
|||||
|
2024
Q3 | $1.02M | Hold |
|
|||||
|
2024
Q2 | $1.78M | Hold |
|
|||||
|
2024
Q1 | $2.71M | Hold |
|
|||||
|
2023
Q4 | $1.94M | Hold |
|
|||||
|
2023
Q3 | $1.27M | Hold |
|
|||||
|
2023
Q2 | $947K | Hold |
|
|||||
|
2023
Q1 | $818K | Hold |
|
|||||
|
2022
Q4 | $2.09M | Buy |
|
|||||
|
2022
Q3 | $2.31M | Hold |
|
|||||
|
2022
Q2 | $1.4M | Hold |
|
|||||
|
2022
Q1 | $6.76M | Sell |
|
|||||
|
2021
Q4 | $5.47M | Sell |
|
|||||
|
2021
Q3 | $8.76M | Buy |
|
|||||
|
2021
Q2 | $2.99M | Hold |
|
|||||
|
2021
Q1 | $3.37M | Hold |
|
|||||
|
2020
Q4 | $3.35M | Hold |
|
|||||
|
2020
Q3 | $2.27M | Hold |
|
|||||
|
2020
Q2 | $5.23M | Hold |
|
|||||
|
2020
Q1 | $3.41M | Hold |
|
|||||
|
2019
Q4 | $4.75M | Hold |
|
|||||
|
2019
Q3 | $1.9M | Buy |
|